LivaNova PLC
Organization details
- Legal name
- LivaNova PLC
- Former names
- Sand Holdco Plc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Year founded
- 2015
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Gloucester
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- LIVN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001639691
- EIN
- 98-1268150
- UK company number
- 09451374
Board of directors
-
Andrea Lynn Saia · DirectorSince 2023
-
Brooke Elizabeth Story · DirectorSince 2022
-
Brooke Story · DirectorSince 2023
-
Damien McDonald · Director · CEOSince 2023
-
Daniel Jeffrey Moore · DirectorSince 2023
-
Donald Zurbay · DirectorSince 2025
-
Donald Zurbay · DirectorSince 2025
-
Francesco Bianchi · DirectorSince 2023
-
Francesco Bianchi · DirectorSince 2015
-
James Christopher Barry · DirectorSince 2023
-
James Christopher, Barry · DirectorSince 2023
-
Jette Nygaard-Andersen · DirectorSince 2026
-
Jette Nygaard-Andersen · DirectorSince 2026
-
Peter M. Wilver · DirectorSince 2023
-
Peter Marshall Wilver · DirectorSince 2022
-
Seng Stacy Enxing · DirectorSince 2023
-
Sharon O'Kane · DirectorSince 2023
-
Stacy Enxing Seng · DirectorSince 2019
-
Susan M. Podlogar · DirectorSince 2024
-
Susan, Podlogar · DirectorSince 2024
-
Todd C. Schermerhorn · DirectorSince 2023
-
Todd Charles Schermerhorn · DirectorSince 2020
-
Vladimir Makatsaria · Director · Chief Executive OfficerSince 2024
-
Vladimir, Makatsaria · DirectorSince 2024
-
William A. Kozy · Director · Chairman and CEOSince 2023
-
William Kozy · DirectorSince 2018
Former directors
-
Alfred Novak · Director2015 – 2022
-
Andre-Michel Ballester · Director2015 – 2016
-
Andrea Lynn Saia · Director2016 – 2023
-
Arthur Rosenthal · Director2015 – 2022
-
Brian Dominic George Sheridan · Director2015 – 2015
-
Damien McDonald · Director2017 – 2023
-
Daniel Jeffrey Moore · Director2015 – 2024
-
Demetrio Franco Mauro · Director2015 – 2015
-
Hugh Morrison · Director2015 – 2021
-
Rosario Bifulco · Director2015 – 2015
-
Sharon O'Kane · Director2015 – 2026
-
Stefano Gianotti · Director2015 – 2018
Chief executives
Strong · grade B
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 79
9.7% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Board connections
8 of this board's directors also sit on 11 other boards. 9 are in the same sector.
-
Align Technology Inc. Same sectorvia Andrea Lynn Saia
-
Baxter International Inc. Same sectorvia Peter M. Wilver
-
DENTSPLY SIRONA Inc. Same sectorvia Donald Zurbay
-
Enovis Corporation Same sectorvia Damien McDonald
-
Outset Medical Inc. Same sectorvia Andrea Lynn Saia
-
PolyPid Ltd. Same sectorvia Brooke Story
- via Peter M. Wilver
-
Sight Sciences Inc. Same sectorvia Donald Zurbay
-
Tevogen Inc. Same sectorvia Susan M. Podlogar
-
The Cooper Companies Inc. Same sectorvia William A. Kozy
- via Todd C. Schermerhorn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,045,857
- 7 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Francesco Bianchi Director | Open-market sale | −3,500 | $78.01 | $273,035 |
| Sep 4, 2026 | Brooke Story Director | Open-market sale | −2,300 | $81.42 | $187,266 |
| Aug 31, 2026 | Francesco Bianchi Director | Open-market sale | −1,650 | $79.72 | $131,538 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Option exercise | +12,692 | $52.68 | $668,615 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Sold back to the company | −8,589 | $77.86 | $668,740 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Shares withheld for tax | −1,428 | $77.86 | $111,184 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Open-market sale | −2,675 | $77.74 | $207,955 |
| Jun 15, 2026 | Peter M. Wilver Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Todd C. Schermerhorn Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Francesco Bianchi Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Susan M. Podlogar Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | James Christopher Barry Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Option exercise | +2,965 | — | — |
| Jun 15, 2026 | William A. Kozy Director | Option exercise | +5,681 | — | — |
| Jun 15, 2026 | Seng Stacy Enxing Director | Option exercise | +4,042 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about LivaNova PLC
Who is the CEO of LivaNova PLC?
Vladimir Makatsaria has been LivaNova PLC's Chief Executive Officer since March 2024.
How many directors are on LivaNova PLC's board?
LivaNova PLC's board has 26 directors: Andrea Lynn Saia, Brooke Elizabeth Story, Brooke Story, Damien McDonald, Daniel Jeffrey Moore, Donald Zurbay, Donald Zurbay, Francesco Bianchi, Francesco Bianchi, James Christopher Barry and 16 others.
Are LivaNova PLC insiders buying or selling shares?
Over the last 12 months, LivaNova PLC insiders made no open-market purchases and sold $1.0 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="livanova-plc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.